Report Detail

Pharma & Healthcare Global Whooping Cough Preventable Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4607935
  • |
  • 19 August, 2024
  • |
  • Global
  • |
  • 96 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Whooping cough preventable vaccine is a vaccine that protects against whooping cough (pertussis). There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
According to our (Global Info Research) latest study, the global Whooping Cough Preventable Vaccine market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Whooping Cough Preventable Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Whooping Cough Preventable Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2019-2030
Global Whooping Cough Preventable Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2019-2030
Global Whooping Cough Preventable Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2019-2030
Global Whooping Cough Preventable Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Whooping Cough Preventable Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Whooping Cough Preventable Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products, Minhai Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Whooping Cough Preventable Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Acellular Vaccines
Whole-Cell Vaccines
Market segment by Application
12 Months Below
12 Months Above
Major players covered
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Whooping Cough Preventable Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Whooping Cough Preventable Vaccine, with price, sales quantity, revenue, and global market share of Whooping Cough Preventable Vaccine from 2019 to 2024.
Chapter 3, the Whooping Cough Preventable Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Whooping Cough Preventable Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Whooping Cough Preventable Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Whooping Cough Preventable Vaccine.
Chapter 14 and 15, to describe Whooping Cough Preventable Vaccine sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Whooping Cough Preventable Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Acellular Vaccines
    • 1.3.3 Whole-Cell Vaccines
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Whooping Cough Preventable Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 12 Months Below
    • 1.4.3 12 Months Above
  • 1.5 Global Whooping Cough Preventable Vaccine Market Size & Forecast
    • 1.5.1 Global Whooping Cough Preventable Vaccine Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Whooping Cough Preventable Vaccine Sales Quantity (2019-2030)
    • 1.5.3 Global Whooping Cough Preventable Vaccine Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Sanofi Pasteur
    • 2.1.1 Sanofi Pasteur Details
    • 2.1.2 Sanofi Pasteur Major Business
    • 2.1.3 Sanofi Pasteur Whooping Cough Preventable Vaccine Product and Services
    • 2.1.4 Sanofi Pasteur Whooping Cough Preventable Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Sanofi Pasteur Recent Developments/Updates
  • 2.2 GSK
    • 2.2.1 GSK Details
    • 2.2.2 GSK Major Business
    • 2.2.3 GSK Whooping Cough Preventable Vaccine Product and Services
    • 2.2.4 GSK Whooping Cough Preventable Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 GSK Recent Developments/Updates
  • 2.3 Mitsubishi Tanabe Pharma
    • 2.3.1 Mitsubishi Tanabe Pharma Details
    • 2.3.2 Mitsubishi Tanabe Pharma Major Business
    • 2.3.3 Mitsubishi Tanabe Pharma Whooping Cough Preventable Vaccine Product and Services
    • 2.3.4 Mitsubishi Tanabe Pharma Whooping Cough Preventable Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
  • 2.4 KM Biologics
    • 2.4.1 KM Biologics Details
    • 2.4.2 KM Biologics Major Business
    • 2.4.3 KM Biologics Whooping Cough Preventable Vaccine Product and Services
    • 2.4.4 KM Biologics Whooping Cough Preventable Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 KM Biologics Recent Developments/Updates
  • 2.5 Wuhan Institute of Biological Products
    • 2.5.1 Wuhan Institute of Biological Products Details
    • 2.5.2 Wuhan Institute of Biological Products Major Business
    • 2.5.3 Wuhan Institute of Biological Products Whooping Cough Preventable Vaccine Product and Services
    • 2.5.4 Wuhan Institute of Biological Products Whooping Cough Preventable Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Wuhan Institute of Biological Products Recent Developments/Updates
  • 2.6 Walvax Biotechnology
    • 2.6.1 Walvax Biotechnology Details
    • 2.6.2 Walvax Biotechnology Major Business
    • 2.6.3 Walvax Biotechnology Whooping Cough Preventable Vaccine Product and Services
    • 2.6.4 Walvax Biotechnology Whooping Cough Preventable Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Walvax Biotechnology Recent Developments/Updates
  • 2.7 Chengdu Institute of Biological Products
    • 2.7.1 Chengdu Institute of Biological Products Details
    • 2.7.2 Chengdu Institute of Biological Products Major Business
    • 2.7.3 Chengdu Institute of Biological Products Whooping Cough Preventable Vaccine Product and Services
    • 2.7.4 Chengdu Institute of Biological Products Whooping Cough Preventable Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Chengdu Institute of Biological Products Recent Developments/Updates
  • 2.8 Minhai Biotechnology
    • 2.8.1 Minhai Biotechnology Details
    • 2.8.2 Minhai Biotechnology Major Business
    • 2.8.3 Minhai Biotechnology Whooping Cough Preventable Vaccine Product and Services
    • 2.8.4 Minhai Biotechnology Whooping Cough Preventable Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Minhai Biotechnology Recent Developments/Updates

3 Competitive Environment: Whooping Cough Preventable Vaccine by Manufacturer

  • 3.1 Global Whooping Cough Preventable Vaccine Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Whooping Cough Preventable Vaccine Revenue by Manufacturer (2019-2024)
  • 3.3 Global Whooping Cough Preventable Vaccine Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Whooping Cough Preventable Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Whooping Cough Preventable Vaccine Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Whooping Cough Preventable Vaccine Manufacturer Market Share in 2023
  • 3.5 Whooping Cough Preventable Vaccine Market: Overall Company Footprint Analysis
    • 3.5.1 Whooping Cough Preventable Vaccine Market: Region Footprint
    • 3.5.2 Whooping Cough Preventable Vaccine Market: Company Product Type Footprint
    • 3.5.3 Whooping Cough Preventable Vaccine Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Whooping Cough Preventable Vaccine Market Size by Region
    • 4.1.1 Global Whooping Cough Preventable Vaccine Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Whooping Cough Preventable Vaccine Consumption Value by Region (2019-2030)
    • 4.1.3 Global Whooping Cough Preventable Vaccine Average Price by Region (2019-2030)
  • 4.2 North America Whooping Cough Preventable Vaccine Consumption Value (2019-2030)
  • 4.3 Europe Whooping Cough Preventable Vaccine Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Whooping Cough Preventable Vaccine Consumption Value (2019-2030)
  • 4.5 South America Whooping Cough Preventable Vaccine Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Whooping Cough Preventable Vaccine Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Whooping Cough Preventable Vaccine Sales Quantity by Type (2019-2030)
  • 5.2 Global Whooping Cough Preventable Vaccine Consumption Value by Type (2019-2030)
  • 5.3 Global Whooping Cough Preventable Vaccine Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Whooping Cough Preventable Vaccine Sales Quantity by Application (2019-2030)
  • 6.2 Global Whooping Cough Preventable Vaccine Consumption Value by Application (2019-2030)
  • 6.3 Global Whooping Cough Preventable Vaccine Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Whooping Cough Preventable Vaccine Sales Quantity by Type (2019-2030)
  • 7.2 North America Whooping Cough Preventable Vaccine Sales Quantity by Application (2019-2030)
  • 7.3 North America Whooping Cough Preventable Vaccine Market Size by Country
    • 7.3.1 North America Whooping Cough Preventable Vaccine Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Whooping Cough Preventable Vaccine Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Whooping Cough Preventable Vaccine Sales Quantity by Type (2019-2030)
  • 8.2 Europe Whooping Cough Preventable Vaccine Sales Quantity by Application (2019-2030)
  • 8.3 Europe Whooping Cough Preventable Vaccine Market Size by Country
    • 8.3.1 Europe Whooping Cough Preventable Vaccine Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Whooping Cough Preventable Vaccine Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Whooping Cough Preventable Vaccine Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Whooping Cough Preventable Vaccine Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Whooping Cough Preventable Vaccine Market Size by Region
    • 9.3.1 Asia-Pacific Whooping Cough Preventable Vaccine Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Whooping Cough Preventable Vaccine Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Whooping Cough Preventable Vaccine Sales Quantity by Type (2019-2030)
  • 10.2 South America Whooping Cough Preventable Vaccine Sales Quantity by Application (2019-2030)
  • 10.3 South America Whooping Cough Preventable Vaccine Market Size by Country
    • 10.3.1 South America Whooping Cough Preventable Vaccine Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Whooping Cough Preventable Vaccine Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Whooping Cough Preventable Vaccine Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Whooping Cough Preventable Vaccine Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Whooping Cough Preventable Vaccine Market Size by Country
    • 11.3.1 Middle East & Africa Whooping Cough Preventable Vaccine Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Whooping Cough Preventable Vaccine Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Whooping Cough Preventable Vaccine Market Drivers
  • 12.2 Whooping Cough Preventable Vaccine Market Restraints
  • 12.3 Whooping Cough Preventable Vaccine Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Whooping Cough Preventable Vaccine and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Whooping Cough Preventable Vaccine
  • 13.3 Whooping Cough Preventable Vaccine Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Whooping Cough Preventable Vaccine Typical Distributors
  • 14.3 Whooping Cough Preventable Vaccine Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Whooping Cough Preventable Vaccine. Industry analysis & Market Report on Whooping Cough Preventable Vaccine is a syndicated market report, published as Global Whooping Cough Preventable Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Whooping Cough Preventable Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,634.36
    3,951.54
    5,268.72
    3,132.00
    4,698.00
    6,264.00
    494,682.00
    742,023.00
    989,364.00
    291,380.40
    437,070.60
    582,760.80
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report